Home » Topics » Science » New compound

New compound
RSS

New dual orexin receptor agonists for the treatment of orexin-deficient disorders such as narcolepsy

Aug. 25, 2021

Small-molecule degrader targets phospho-AKT and inhibits growth of PI3K/PTEN pathway mutant cancers

Aug. 24, 2021

[11C]MTP-38 first use in human PET studies shows promise for neurological disorders

Aug. 20, 2021

China Pharmaceutical University targets WDR5/MLL1 interaction with DDO-2213

Aug. 12, 2021

KV-998083 effective in models of thrombosis and vascular leakage

July 30, 2021

Ghent University Hybrid CAR-T cell platform has dual anti-HIV effects

July 28, 2021

CFT-2718 shows promising tumor growth reduction in models of SCLC

July 23, 2021

Discovery of novel siderophore-monobactam conjugates against P. Aeruginosa

July 15, 2021

TP-03 enhances the stimulating effect of hCG on testicular steroidogenesis

July 14, 2021

VRG-101: a new PIKfyve inhibitor for SARS-CoV-2

July 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...